Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_assertion type Assertion NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_head.
- NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_provenance.
- NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_assertion evidence source_evidence_literature NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_provenance.
- NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_assertion SIO_000772 23733802 NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_provenance.
- NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_assertion wasDerivedFrom befree-20150227 NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_provenance.
- NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_assertion wasGeneratedBy ECO_0000203 NP411856.RAjS8Zd0FOk4Yn3dTROt_DCzdxDrCVwy4t5mGQsNgb2SA130_provenance.